The use of psychotropic medication during pregnancy: how about the newborn?

Noera Kieviet,1 Koert M Dolman,1 Adriaan Honig2 1Department of Paediatrics, 2Department of Psychiatry, Psychiatry Obstetrics Paediatrics Expert Center, Sint Lucas Andreas Hospital, Amsterdam, The Netherlands Abstract: Infants are at risk of developing symptoms of Poor Neonatal Adaptation (PNA) after...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Kieviet N, Dolman KM, Honig A
Formato:	article
Lenguaje:	EN
Publicado:	Dove Medical Press 2013
Materias:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Acceso en línea:	https://doaj.org/article/0c6dccab5427439b9b4807321cb2dd67
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:0c6dccab5427439b9b4807321cb2dd67
record_format	dspace
spelling	oai:doaj.org-article:0c6dccab5427439b9b4807321cb2dd672021-12-02T07:50:34ZThe use of psychotropic medication during pregnancy: how about the newborn?1176-63281178-2021https://doaj.org/article/0c6dccab5427439b9b4807321cb2dd672013-08-01T00:00:00Zhttp://www.dovepress.com/the-use-of-psychotropic-medication-during-pregnancy-how-about-the-newb-a14197https://doaj.org/toc/1176-6328https://doaj.org/toc/1178-2021Noera Kieviet,1 Koert M Dolman,1 Adriaan Honig2 1Department of Paediatrics, 2Department of Psychiatry, Psychiatry Obstetrics Paediatrics Expert Center, Sint Lucas Andreas Hospital, Amsterdam, The Netherlands Abstract: Infants are at risk of developing symptoms of Poor Neonatal Adaptation (PNA) after exposure to psychotropic drugs in utero. Such symptoms are largely similar after exposure to antidepressants, antipsychotics and benzodiazepines and consist of mostly mild neurologic, autonomic, respirator and gastro-intestinal abnormalities. Most symptoms develop within 48 hours after birth and last for 2–6 days. After exposure to Selective Serotonin Reuptake Inhibitors (SSRIs), mirtazapine or venlafaxine in utero, breastfeeding is presumably protective for development of PNA. The dosage of antidepressants does not seem to be related to the risk of PNA. In order to objectify possible symptoms of PNA, observation of mother and child at the maternity ward is advisable. If PNA symptoms do not occur, an observation period of 48–72 hours is sufficient. This applies to all types of psychotropic drugs. When PNA symptoms are present it is advisable to observe the infant until the symptoms are fully resolved. Observation can be performed by trained nurses using the Finnegan scoring list. This observation list should be administered every 8 hours. Interpretation of the scores should be carried out by a paediatrician. In most cases symptoms are non-specific. Therefore other diagnoses, such as infection or neurologic problems, have to be excluded. When there is any doubt on possible intoxications during pregnancy, toxicological urine screening is indicated. Most cases of PNA are mild, of short duration and self-limiting without need for treatment. Supporting measures such as frequent small feedings, swaddling and increase of skin to skin contact with the mother is usually sufficient. In case of severe PNA it is advised to admit the infant to the Neonatal Care Unit (NCU). Phenobarbital is a safe therapeutic option. There seem to be no major long term effects; however, additional studies are necessary in order to draw definite conclusions. Keywords: withdrawal, neonatal abstinence, psychiatric disorders, SSRI, antidepressantsKieviet NDolman KMHonig ADove Medical PressarticleNeurosciences. Biological psychiatry. NeuropsychiatryRC321-571Neurology. Diseases of the nervous systemRC346-429ENNeuropsychiatric Disease and Treatment, Vol 2013, Iss default, Pp 1257-1266 (2013)
institution	DOAJ
collection	DOAJ
language	EN
topic	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
spellingShingle	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429 Kieviet N Dolman KM Honig A The use of psychotropic medication during pregnancy: how about the newborn?
description	Noera Kieviet,1 Koert M Dolman,1 Adriaan Honig2 1Department of Paediatrics, 2Department of Psychiatry, Psychiatry Obstetrics Paediatrics Expert Center, Sint Lucas Andreas Hospital, Amsterdam, The Netherlands Abstract: Infants are at risk of developing symptoms of Poor Neonatal Adaptation (PNA) after exposure to psychotropic drugs in utero. Such symptoms are largely similar after exposure to antidepressants, antipsychotics and benzodiazepines and consist of mostly mild neurologic, autonomic, respirator and gastro-intestinal abnormalities. Most symptoms develop within 48 hours after birth and last for 2–6 days. After exposure to Selective Serotonin Reuptake Inhibitors (SSRIs), mirtazapine or venlafaxine in utero, breastfeeding is presumably protective for development of PNA. The dosage of antidepressants does not seem to be related to the risk of PNA. In order to objectify possible symptoms of PNA, observation of mother and child at the maternity ward is advisable. If PNA symptoms do not occur, an observation period of 48–72 hours is sufficient. This applies to all types of psychotropic drugs. When PNA symptoms are present it is advisable to observe the infant until the symptoms are fully resolved. Observation can be performed by trained nurses using the Finnegan scoring list. This observation list should be administered every 8 hours. Interpretation of the scores should be carried out by a paediatrician. In most cases symptoms are non-specific. Therefore other diagnoses, such as infection or neurologic problems, have to be excluded. When there is any doubt on possible intoxications during pregnancy, toxicological urine screening is indicated. Most cases of PNA are mild, of short duration and self-limiting without need for treatment. Supporting measures such as frequent small feedings, swaddling and increase of skin to skin contact with the mother is usually sufficient. In case of severe PNA it is advised to admit the infant to the Neonatal Care Unit (NCU). Phenobarbital is a safe therapeutic option. There seem to be no major long term effects; however, additional studies are necessary in order to draw definite conclusions. Keywords: withdrawal, neonatal abstinence, psychiatric disorders, SSRI, antidepressants
format	article
author	Kieviet N Dolman KM Honig A
author_facet	Kieviet N Dolman KM Honig A
author_sort	Kieviet N
title	The use of psychotropic medication during pregnancy: how about the newborn?
title_short	The use of psychotropic medication during pregnancy: how about the newborn?
title_full	The use of psychotropic medication during pregnancy: how about the newborn?
title_fullStr	The use of psychotropic medication during pregnancy: how about the newborn?
title_full_unstemmed	The use of psychotropic medication during pregnancy: how about the newborn?
title_sort	use of psychotropic medication during pregnancy: how about the newborn?
publisher	Dove Medical Press
publishDate	2013
url	https://doaj.org/article/0c6dccab5427439b9b4807321cb2dd67
work_keys_str_mv	AT kievietn theuseofpsychotropicmedicationduringpregnancyhowaboutthenewborn AT dolmankm theuseofpsychotropicmedicationduringpregnancyhowaboutthenewborn AT honiga theuseofpsychotropicmedicationduringpregnancyhowaboutthenewborn AT kievietn useofpsychotropicmedicationduringpregnancyhowaboutthenewborn AT dolmankm useofpsychotropicmedicationduringpregnancyhowaboutthenewborn AT honiga useofpsychotropicmedicationduringpregnancyhowaboutthenewborn
_version_	1718399142118555648

The use of psychotropic medication during pregnancy: how about the newborn?

Ejemplares similares